AZT resistance of simian foamy virus reverse transcriptase is based on the excision of AZTMP in the presence of ATP by Hartl, Maximilian J. et al.
Published online 20 December 2007 Nucleic Acids Research, 2008, Vol. 36, No. 3 1009–1016
doi:10.1093/nar/gkm1087
AZT resistance of simian foamy virus reverse
transcriptase is based on the excision of AZTMP
in the presence of ATP
Maximilian J. Hartl
1, Benedikt Kretzschmar
2, Anne Frohn
1, Ali Nowrouzi
2,
Axel Rethwilm
2 and Birgitta M. Wo ¨hrl
1,*
1Universita ¨t Bayreuth, Lehrstuhl fu ¨r Struktur und Chemie der Biopolymere & Research Center for Biomacromolecules,
95440 Bayreuth and
2Universita ¨tW u ¨rzburg, Institut fu ¨r Virologie und Immunbiologie, Wu ¨rzburg, Germany
Received September 25, 2007; Revised November 17, 2007; Accepted November 19, 2007
ABSTRACT
Azidothymidine (AZT, zidovudine) is one of the few
nucleoside inhibitors known to inhibit foamy virus
replication. We have shown previously that up to
four mutations in the reverse transcriptase gene of
simian foamy virus from macaque (SFVmac) are
necessary to confer high resistance against AZT.
To characterize the mechanism of AZT resistance
we expressed two recombinant reverse transcrip-
tases of highly AZT-resistant SFVmac in Escherichia
coli harboring three (K211I, S345T, E350K) or four
mutations (K211I, I224T, S345T, E350K) in the
reverse transcriptase gene. Our analyses show
that the polymerization activity of these mutants is
impaired. In contrast to the AZT-resistant reverse
transcriptase of HIV-1, the AZT resistant enzymes of
SFVmac reveal differences in their kinetic proper-
ties. The SFVmac enzymes exhibit lower specific
activities on poly(rA)/oligo(dT) and higher KM-values
for polymerization but no change in KD-values for
DNA/DNA or RNA/DNA substrates. The AZT resis-
tance of the mutant enzymes is based on the
excision of the incorporated inhibitor in the pre-
sence of ATP. The additional amino acid change of
the quadruple mutant appears to be important for
regaining polymerization efficiency.
INTRODUCTION
Foamy viruses belong to the retroviridae but follow a
replication pattern unique among retroviruses: (i) reverse
transcription occurs before the virus leaves the host cell,
(ii) the pol-gene is expressed from an separate mRNA
and (iii) the viral protease is not cleaved oﬀ the
Pol-polyprotein (1,2). Only the integrase is removed from
Pol (3). Thus, the FV reverse transcriptase (PR–RT)
harbors a protease, polymerase and RNase H domain.
Apart form the nucleoside inhibitor tenofovir, only
azidothymidine (AZT, zidovudine) is known to inhibit FV
reverse transcriptase in vivo in cell culture assays at
concentrations as low as 5mM (4–6). We have shown
recently that four point mutations involving the amino
acids 211 (K211I), 224 (I224T) 345 (S345T) and 350
(E350K) located in the PR–RT gene are involved in AZT
resistance of SFVmac. The fully resistant SFVmac virus
harboring all four mutations was able to replicate in the
presence of 1mM AZT (7). While AZT resistance in
HIV-1 is based on the excision of incorporated AZT-
monophosphate (AZTMP), AZT-resistant HIV-2 can
distinguish between AZT-triphosphate (AZTTP) and
TTP during incorporation (8–11).
For FVs, the resistance mechanism is not known. To
elucidate the mechanism of AZT resistance we set out to
express partially and fully AZT-resistant SFVmac
PR–RTs harboring either three or all four AZT resistance
mutations in Escherichia coli. We were able to show that
the mechanism of AZT resistance in SFVmac PR–RTs is
based on AZTMP excision from a terminated primer in
the presence of ATP. Although the resistant PR–RTs are
impaired in their polymerase activities, the faster excision
of AZTMP in the presence of ATP confers high resistance
against AZT. The I224 mutation appears to be primarily
important for regaining polymerization activities for
eﬃcient viral replication.
MATERIALS AND METHODS
Cloning,expression andpurification of PR–RTs
The wild-type PR–RT gene was cloned into the vector
pET28c (Novagen, Germany) via PCR ampliﬁcation
and by using the restriction sites XhoI and NcoI.
Present address:
Anne Frohn, Max Planck Institut fu ¨ r Biochemie, Martinsried, Germany
*To whom correspondence should be addressed. Tel: +49 921 55 3542; Fax: +49 921 55 3544; Email: birgitta.woehrl@uni-bayreuth.de
 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.The expressed proteins contain a 6  His tag at the
C-terminus. To avoid degradation of the PR–RT by
autocatalytic activity of the PR, a mutant enzyme was
constructed harboring an active site mutation in the PR
region (D24A), which leads to an inactive PR. Thus the
AZT-resistant mutants also contain the D24A mutation in
the PR. The AZT-resistance mutations were created by
site-directed mutagenesis according to the QuickChange
kit from Stratagene (Heidelberg, Germany). The following
potentially AZT-resistant PR–RT mutants were obtained:
mt3: (D24A) K211I, S345T, E350K
mt4: (D24A) K211I, I224T, S345T, E350K
The activities of the mutants were compared to wild-
type PR–RT either without or with the PR D24A
mutation (WT and WT
 , respectively).
The corresponding plasmids were transformed into the
E. coli strain Rosetta (DE3) (Novagen, Germany).
Expression of the PR–RT genes was induced at an optical
density of the culture of ca. 0.8–1.0 at 600nm by the
addition of 0.2mM IPTG and incubated further over
night at 258C. The enzymes were puriﬁed via Ni-aﬃnity
chromatography (HisTrap, GE Healthcare, Munich,
Germany), followed by chromatography over a heparin
column (HiTrap heparin, GE Healthcare, Munich,
Germany). The integrity of the proteins was veriﬁed by
peptide mass ﬁngerprints (Zentrale Bioanalytik, Zentrum
fu ¨ r Molekulare Medizin, Ko ¨ ln, Germany). The purity of
the proteins was >95% as judged by SDS–PAGE.
Quantitative polymerization assay
RNA-dependent DNA polymerase activity was quanti-
tated on a poly(rA)/oligo(dT)15 substrate (0.2U/ml)
(Roche Diagnostics GmbH, Mannheim, Germany) in a
standard assay (30ml reaction volume) as described
previously (12,13) with 150mM TTP and 41.7Ci/ml
[
3H]TTP (49.9Ci/mmol; MP Biomedicals Inc., Irvine,
CA, USA) in reaction buﬀer [50mM Tris/HCl, pH 8.0,
80mM KCl, 6mM MgCl2, 0.5mM dithiothreitol (DTT),
0.05% Triton X-100]. Samples were pre-incubated for
2min at 378C. The reaction was started by the addition of
12nM of PR–RT. After 10min, 7.5ml aliquots were taken
out and spotted on DEAE ﬁlter paper and treated as
described (12,13). Under these conditions 1 U of enzyme
activity catalyzes the incorporation of 1nmol of TTP into
poly(rA)/oligo(dT)15 in 10min at 378C. For the determi-
nation of KM and vmax values, reactions were performed
with increasing concentrations of TTP of 25, 50, 75 or
125mM. KM– and vmax–values were calculated by linear
regression using Eadie–Hofstee plots.
5’-endlabeling ofprimers
One hundred picomoles of M13 primer (50-GTAAAA
CGACGGCCAGT) or P30 primer (GCTCTAATGGCG
TCCCTGTTCGGGCGCCTC) (IBA, Go ¨ ttingen,
Germany) was labeled with 60mCi g[
32P]-ATP with 2U
T4 polynucleotide kinase (New England Biolabs,
Frankfurt, Germany) for 1h at 378C. After inactivation
of the kinase for 20min at 658C the primer was puriﬁed via
a MicroSpin column (GE Healthcare, Munich, Germany).
Chain termination assay
Chain termination assays were performed using single-
stranded M13mp18 (Roche Diagnostics GmbH,
Mannheim, Germany). The 50 32P-labeled M13 primer
was hybridized to a 1.2-fold molar excess of the M13
DNA in a buﬀer containing 50mM Tris/HCl, pH 8.0 and
80mM KCl by heating to 958C for 2min, followed by a
transfer to a heating block at 708C and slow cooling to
room temperature. Reaction mixtures contained 6nM of
primer/template substrate (P/T), 85nM of PR–RT,
150mM of each dNTP and increasing concentrations of
AZTTP (GeneCraft GmbH, Lu ¨ dinghausen, Germany) in
a total volume of 10ml. After a pre-incubation time of
5min, reactions were carried out for 10min at 378Ci n
reaction buﬀer (see above). Reactions were stopped by
adding 10ml of urea loading buﬀer [1mM EDTA, 0.1%
xylene cyanole, 0.1% bromophenol blue, 8M urea in
1 TBE (Tris/Borate/EDTA)] and analyzed by denatur-
ing gel electrophoresis (10% polyacrylamide, 7M urea).
The reaction products were visualized by autoradiography
or phosphoimaging and quantitated by densitometry
using a phosphoimaging device (FLA 3000, raytest,
Straubenhardt, Germany).
Fluorescence anisotropymeasurements
Fluorescence equilibrium titrations were performed to
determine the dissociation constants (KD) for nucleic acid
binding with a 24/40-mer DNA/DNA or DNA/RNA
P/T substrate with the following sequences for the primer
50-ATCACCAGGAGAGGGGAAAGCGGA and tem-
plate 50-DY647-CTAATTCCGCTTTCCCCTCTCCTG
GTGATCCTTTCCATCC (biomers.net GmbH, Ulm,
Germany). The RNA template sequence was identical,
containing U instead of T. The templates harbored the
ﬂuorescent dye DY647at their 50 ends. Titrations were
performed in ﬂuorescence buﬀer (50mM Tris/HCl, pH
8.0; 80mM KCl, 10mM EDTA, 0.5mM DTT) in a total
volume of 1 or 2ml using a 10 4mm quartz cuvette
(Hellma GmbH, Mu ¨ hlheim, Germany). The excitation
wavelength was at 552nm, and the emission intensity was
measured at 573nm. Slit widths were set at 4.9 and 5.0nm
for excitation and emission, respectively. All anisotropy
measurements were performed at 258C with 15nM of
ﬂuorescently labeled P/T using an L-format Jobin-Yvon
Horiba Fluoromax ﬂuorimeter equipped with an auto-
matic titration device (Hamilton). Following sample
equilibration, at least six data points with an integration
time of 1s were collected for each titration point.
Data fitting. Data were ﬁtted to a two-component
binding equation to determine the equilibrium dissocia-
tion constant (KD) using standard software. The aniso-
tropy was calculated from:
A ¼ fcomplex Acomplex þ fRNA ARNA 1
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values and fcomplex,f RNA the fractional intensities. The
change in ﬂuorescence intensity has to be taken into
account, so that the fraction bound is given by
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where A is the anisotropy, ARNA is the initial free
anisotropy, Acomplex is the anisotropy of the protein–
RNA complex and P0 and RNA0 represent the total
protein and RNA concentrations, respectively. R is the
ratio of intensities of the bound and free forms.
Termination ofthe radioactively labeled P/T withAZTTP
The [
32P] end labeled P30 DNA primer was hybridized to a
template deoxyoligonucleotide T50 (50-GCTGTGGAAAA
TCTCATGCAGAGGCGCCCGAACAGGGACGCCA
TTACAGC) (IBA; Go ¨ ttingen, Germany) as described
for the M13 DNA and used for incorporation of AZTTP.
P30/T50 measuring 100nM were mixed with 100mM
AZTTP and 150nM WT PR–RT in reaction buﬀer and
incubated for 2h at 378C. After phenol extraction and
ethanol precipitation, the P/T substrate was puriﬁed over
two MicroSpin columns (GE Healthcare, Munich,
Germany) to eliminate protein and excess AZTTP.
Excision assay
Ten nanomolar of the [
32P] P30-AZTMP/T50 substrate were
incubated with 20nM PR–RT in a volume of 10mli n
reaction buﬀer for the times indicated. Either 150mMo f
Na-pyrophosphate (PPi) or 5mM of ATP was present in
the mixture. Reactions were started by the addition of
enzyme. Where stated, the samples were pre-incubated for
5min with 0.02U of pyrophosphatase (Sigma–Aldrich
Chemie GmbH, Taufkirchen, Germany). When diﬀerent
concentrations of PR–RTs were tested, the reactions were
stopped after 20min. An equal volume of urea loading
buﬀer was added and the products were analyzed as stated
above on denaturing polyacrylamide urea gels.
Primer rescue
One hundred micromolar of dCTP, dGTP, TTP and
ddATP was added to the samples with 5mM ATP
described above to allow for elongation by 4nt once the
AZTMP is excised. Samples were pre-incubated for 5min
with 0.02U of pyrophosphatase before the reaction was
started with 40nM of PR–RT. Reactions were stopped
after 10min and treated further as described above.
RESULTS
We have shown previously that it is possible to generate
AZT-resistant SFVmac in cell culture which is able to
replicate in medium containing 1mM AZT (7). Four
mutations were necessary to confer high resistance to the
virus: K211I, I224T, S345T and E350K. Since one
published genomic sequence of wild-type SFVmac already
harbors a threonine at position 224 of Pol and since
several other primate FV Pol proteins also possess a
threonine at position 224, the wild-type SFVmac might
have a polymorphism at this site. Thus, we decided to
analyze a triple mutant PR–RT lacking the I224T
mutation [mt3;( D24A), K211I, S345T and E350K] as
well as the quadruple mutant harboring I224T [mt4;
(D24A), K211I, I224T, S345T and E350K]. To avoid
autoprocessing of the PR domain, the enzymes also
contained a D24A amino acid exchange in the active site
of the PR. Our data below indicate that this mutation does
not inﬂuence the polymerization activities of the mutants.
The puriﬁed enzymes were used to determine kinetic
parameters of polymerization and to analyze the AZT
resistance mechanism.
Polymerization activities
In order to characterize the AZT-resistant PR–RT
enzymes we performed various polymerization assays.
First, the speciﬁc activities of the enzymes were deter-
mined by observing the
3H-TTP incorporation into
poly(rA)/oligo(dT)15 (Table 1). Our results indicate that
the D24A mutation of the WT
  does not interfere with
polymerization activities. Furthermore, the activity of mt3
is reduced to  38% of WT activity, whereas the
additional mutation I224T of mt4 helps this enzyme to
regain activity (80% of WT). These eﬀects are even more
pronounced regarding the replication activity of the
corresponding mutant viruses (7): the virus replication
activity of the virus containing mt3 was severely reduced
(8.6% of WT) whereas the virus containing mt4 displayed
a replication activity similar to the WT virus (113%
of WT).
Dissociation constants
As shown above, polymerization activities of the two
mutants are impaired. Since this might have an impact on
AZT resistance, we wanted to analyze some kinetic
parameters. To check if the reduced polymerization
activity is due to changes in the aﬃnity for nucleic acids,
Table 1. Quantitative analysis of RNA-dependent DNA polymerase
activities on a homopolymeric substrate
Enzyme U/mg protein
 10min
WT 30.9 (  0.9)
WT
  31.5 (  0.1)
mt3 11.6 (  0.2)
mt4 24.6 (  0.7)
Activities are given in units per microgram of protein, where 1U
catalyzes the incorporation of 1nmol TTP in poly(rA)/oligo(dT)15 in
10min at 378C.
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Measurements were performed using ﬂuorescence aniso-
tropy titrations with 24/40mer DNA/RNA or DNA/DNA
P/T substrates harboring a ﬂuorescent dye (DY647) at the
50 end of the template strand (Table 2, Figure 1). The
KD-values obtained show that there is no signiﬁcant
diﬀerence in substrate binding aﬃnities of WT and mutant
enzymes, implying that neither the D24A mutation nor the
AZT-resistance mutations inﬂuence substrate binding.
The aﬃnity for the DNA/RNA substrate appears to be
slightly higher than for DNA/DNA.
Determination ofKM and vmaxvalues
This analysis was performed using poly(rA)/oligo(dT)15 as
a substrate (Table 2). Both AZT-resistant enzymes, mt3
and m4, reveal elevated KM-values as compared to the two
WT proteins. However, the vmax value of mt4 is higher
than that of mt3 and comparable to the WT proteins,
indicating that mt4 is able to exhibit similar polymeriza-
tion activities like the WT at saturating dNTP concentra-
tions. This might explain the high virus replication
activities observed with mt4 containing virus in cell
culture assays (7).
Polymerization in thepresence of AZTTP
Two mechanisms for AZT resistance have been described.
HIV-2 RT controls the incorporation of the inhibitor
nucleotide AZTTP (11), whereas for HIV-1 RT excision of
the incorporated AZTMP has been recognized as the
mechanism of resistance (8–10). Thus, we ﬁrst analyzed
the polymerization behavior of the enzymes in the
presence of AZTTP to check for incorporation control.
We performed polymerization assays on poly(rA)/
oligo(dT)15 in the presence of increasing AZTTP concen-
trations up to 150mM (Figure 2A). The TTP concentra-
tion was kept constant (150mM) in all assays. Our data
indicate that mt3 and mt4 do not exhibit AZT resistance
in this assay.
We then used the heteropolymeric single-stranded M13
substrate with a
32P-endlabeled DNA-primer for poly-
merization in the absence of inhibitor or in the presence of
5 and 50mM AZTTP and analyzed the polymerization
products on denaturing polyacrylamide gels (Figure 2B).
As already described for the homopolymeric substrate, all
enzymes are sensitive to AZTTP addition in the M13
assay. This result is reminiscent of HIV-1 RT (14), where
the AZT resistance was also not visible in steady-state
polymerization assays or during pre-steady-state analyses
and could only be detected with an AZTMP-terminated
P/T substrate (8–10). Our results indicate that the
resistance mechanism of SFVmac PR–RTs is not compar-
able to HIV-2 RT where discrimination between the
inhibitor and TTP takes place during incorporation (11).
AZTMP excision formaterminated primer
For HIV-1 RT, it has been shown previously that AZTMP
can be excised from an AZTMP-terminated P/T substrate
in the presence of PPi or ATP (8–10). We thus tested these
possibilities.
The
32P-endlabeled and AZTMP-terminated substrate
P30-AZTMP/T50 was incubated with 150mM Na-PPi or
5mM ATP and PR–RT. Time course experiments were
performed (Figures 3 and 4) and aliquots were analyzed
on denaturing sequencing gels and quantiﬁed by densito-
metry. Our data indicate that in the presence of PPi the
WT
  PR–RT can excise AZTMP from the terminated
primer with similar eﬃciency as mt3 or mt4 (Figure 3B).
Obviously, the ability to perform the reverse reaction of
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Figure 1. Determination of KD-values by ﬂuorescence anisotropy
measurements. Fifteen nanomolar of a ﬂuorescently labeled DNA/
DNA (A) or DNA/RNA (B) P/T substrate was titrated with diﬀerent
PR–RTs at 258C. The curves show the best ﬁt to Equation (3)
(‘Materials and methods’ section) describing the binding equilibrium
with KD-values shown in Table 2.
Table 2. Parameters for P/T binding and the incorporation of dNTPs
Enzyme KD
DNA/RNA
(nM)
KD
DNA/DNA
(nM)
KM (mM) Vmax
(pmol/min)
WT 32.4 (  4.2) 36.4 (  2.4) 40.1 (  4.0) 29.6 (  1.7)
WT
  30.4 (  2.4) 44.0 (  3.7) 40.3 (  4.0) 29.6 (  1.3)
mt3 28.3 (  2.7) 39.5 ( 3.0) 103.0 (  16.0) 25.8 (  2.5)
mt4 31.3 (  3.2) 42.4 (  3.0) 112.0 (  4.0) 30.1 (  3.3)
KD-values were obtained by using Equation (3) to ﬁt a curve to
the titration data (see ‘Materials and Methods section’). KM- and
vmax-values were determined by Eadie–Hofstee plots.
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and might be used as a general proof reading function.
In contrast, when ATP is added (Figure 4), even after an
incubation time of 20min the WT
  enzyme does not
exhibit signiﬁcant AZTMP removal activity, whereas mt3
and mt4 are able to excise AZTMP eﬃciently. To exclude
an inﬂuence of PPi in the excision reaction, an additional
assay was performed after pre-incubating the reaction mix
with pyrophosphatase (Figure 4B). The results shown in
Figure 4A and B look very similar, indicating that only
insigniﬁcant amounts of PPi were present in the reactions.
Quantiﬁcation of the data of Figure 4B by densitometry
(Figure 4C) demonstrates that the excision reactions of
mt3 and mt4 are much faster than that of the WT
 .
However, they slow down when about 10% of the
incorporated AZTMP is eliminated from the primer.
This might be due to product inhibition by AZTp4A (15).
These data clearly indicate that AZTMP excision in the
presence of ATP is the valid mechanism for AZT
resistance of SFVmac.
To substantiate our results, we performed the excision
reactions with ATP using increasing concentrations of
enzyme (Figure 5). The assays were also pre-incubated
with pyrophosphatase. Again, our results demonstrate
very clearly that in the presence of ATP the mutant
enzymes are more eﬃcient in AZTMP removal than the
WT
 . Furthermore, in the case of the mutants, large excess
of enzyme leads to the excision of more than one
nucleotide.
Primerrescue
The data delineated above are further conﬁrmed by testing
the enzymes in the presence of dNTPs to allow for
extension of the primer after AZTMP removal (Figure 6).
The assay was performed in the presence of ATP and
pyrophosphatase. Due to the addition of ddATP, elonga-
tion of the primer comes to a halt after the incorporation
of 4nt. Figure 6 shows that only mt3 or mt4 can rescue
DNA synthesis, whereas the WT
  enzyme is not able to
extend the primer.
We thus conclude that AZT resistance of SFVmac
is due to AZTMP removal by ATP. Furthermore, the
AZTMP excision activity obtained with the triple mutant
is comparable to that of mt4. This data indicates that the
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Figure 3. Time course of AZTMP removal in the presence of PPi.
(A) One hundred micro molar NaPPi was present in a mix containing
10nM of an AZTMP-terminated P/T P30-AZTMP/T50 that was labeled
with
32P at the 50 end of the primer. The reaction was started by the
addition of 20nM of the diﬀerent PR–RTs and stopped at the time
points indicated. Lane C, no enzyme added. (B) Quantiﬁcation of
pyrophosphorolytic removal of chain-terminating AZTMP was
achieved by densitometry. The percentage of remaining terminated
primer is shown.
Nucleic Acids Research, 2008, Vol. 36, No. 3 1013additional I224T change of mt4 is not important for the
AZT-resistance mechanism but is necessary to improve
the polymerization eﬃciency.
DISCUSSION
We have shown previously that SFVmac can gain
resistance to the nucleoside inhibitor AZT (7). Here, we
analyzed the corresponding mutated PR–RTs to elucidate
the mechanism of AZT resistance. Our results obtained
with puriﬁed SFVmac PR–RTs demonstrate that in the
case of SFVmac the AZT-resistance mechanism is due to
AZTMP removal in the presence of ATP. Remarkably,
mt3 which exhibited severely impaired polymerization
activities on homo- and heteropolymeric substrates
(Table 1 and Figure 2) also shows higher AZTMP
excision activities than the WT
  enzyme when ATP is
present in the reaction (Figures 4–6). Although mt3 and
mt4 are also able to excise AZTMP in the presence of PPi
(Figure 3) the WT
  PR–RT exhibits similar eﬃciency in
this reaction, indicating that this cannot be the mechanism
of AZT resistance.
Interestingly, compared to the WT SFVmac PR–RTs,
mt3 and mt4 exhibit diﬀerences in kinetic parameters. This
is also noteworthy since the AZT-resistant HIV-1 RT did
not diﬀer from the WT HIV-1 RT in its kinetic parameters
(14,16–18). The KM values of the mutant SFVmac
PR–RTs are about 2.5-fold higher than those of the WT
PR–RTs. While mt3 also shows a reduced value for vmax,
the I224T mutation of mt4 is obviously responsible for an
increase of vmax similar to that of the WT levels (Table 2),
implying that if saturating dNTP concentrations are
present in infected cells, reverse transcription will not be
greatly impaired in SFVmac viruses harboring mt4. This
result indicates that the mutation I224T is important for
viral ﬁtness since it can reconstitute the polymerization
activity of mt4 in SFVmac-infected cells (7).
It has been demonstrated previously that the RTs of
HIV-1 and HIV-2 use diﬀerent mechanisms for AZT
resistance. HIV-2 can discriminate between AZTTP and
TTP during nucleotide incorporation (11). In contrast,
although certain HIV-1 RT mutations confer a 100-fold
decrease in the sensitivity to AZT in vivo (19,20), this eﬀect
could not be demonstrated in in vitro assays (14,16–18),
indicating that HIV-1 RT is not able to discriminate
between AZTTP and TTP. In fact, the mechanism appears
to be due to a removal of the chain terminating AZTMP
residue after it has been incorporated in the DNA chain.
The mutations involved in the enhanced excision of
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Figure 4. Time course of AZTMP removal in the presence of ATP.
(A) Five millimolar ATP was present in a mix containing 10nM of the
AZTMP-terminated P/T P30-AZTMP/T50 that was labeled with
32P at the
50 end of the primer. The reaction was started by the addition of 20nM
of the diﬀerent PR–RTs and stopped at the time points indicated.
(B) Addition of 0.02U pyrophosphatase to the mixture described in
(A) 5min before the PR–RT enzymes were added. Lane C, no enzyme
added. (C) Quantiﬁcation of (B) by densitometry. The percentage of
remaining terminated primer is shown.
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Figure 6. ATP-dependent rescue of AZTMP terminated DNA synth-
esis. (A) Primer rescue reactions using 10nM P30-AZTMP/T50 were
performed with 5mM ATP, 0.02U pyrophosphatase and 100mM
dCTP, dGTP, TTP and ddATP. Lane C, no enzyme added.
(B) Quantiﬁcation of (A) by densitometry. The percentage of the
remaining unextended primer is shown.
Figure 5. AZTMP removal by ATP in the presence of pyrophosphatase
using increasing PR–RT concentrations. Five millimolar ATP and
10nM of P30-AZTMP/T50 were pre-incubated for 5min at 378Ci n
reaction mix. The reaction was started by the addition of diﬀerent
concentrations of the various PR–RTs as indicated and stopped after
20min. Lane C, no enzyme added.
1014 Nucleic Acids Research, 2008, Vol. 36, No. 3AZTMP in HIV-1 RT are M41L, D67N, K70R, T215Y/F
and K219Q/E (Figure 7) (8–10,21,22). Removal of the
inhibitor was suggested to be accomplished by two
mechanisms that use diﬀerent substrates to carry out the
reaction. AZTMP removal can take place either in the
presence of PPi or ATP. The chemistry involved in
pyrophosphorolysis and the ribonucleotide-dependent
phosphorolysis reaction is similar. Removal of the
chain-terminating AZT results from nucleophilic attack
of a polyphosphate in the phosphodiester bond between
the last but one nucleotide and the AZTMP. In case of
PPi, this leads to removal of the 30 AZTMP by creating
AZTTP.
There is evidence that the phosphate donor in the
excision reaction of AZT-resistant HIV-1 RT is ATP,
leading to an ATP-AZTMP dinucleotide-tetraphosphate
(adenosine-30azido,30deoxthymidine-50-50-tetraposphate,
AZTp4A). For HIV-1 RT it was concluded from
biochemical and structural data that the exchange of
T215 to an aromatic residue (T215F/Y) enhances binding
of ATP, but not PPi, thus facilitating excision. The model
suggests that in the AZT-resistant enzyme, the adenine
moiety of the incoming ATP makes  –  interactions with
the aromatic ring of the mutated amino acid (22–26).
Our results obtained with SFVmac PR–RT are espe-
cially interesting when comparing the AZT-resistance
mutations of HIV-1 RT and SFVmac PR–RT since in
the latter enzyme no mutation leading to an aromatic side
chain is present. In addition, sequence alignments of the
polymerase domains of HIV-1 and SFVmac reveal that
the amino acid exchanges obtained with SFVmac are not
the ones corresponding to the exchanges in HIV-1 RT
(Figure 7). Furthermore, although the homology between
PFV and SFVmac is around 90%, introduction of
the SFVmac RT mutations into PFV did not result in
AZT-resistant viruses (7).
These ﬁndings might indicate structural diﬀerences
between HIV-1 and SFVmac RTs. This appears to be
plausible since the RT domains of HIV-1 and SFVmac are
phylogenetically rather distantly related (27). Thus, the
interpretation of alignment data is also rather diﬃcult. In
addition, diﬀerences in the mechanism of ATP binding
and/or ATP-mediated excision are possible. Structural
analysis of WT and AZT-resistant SFVmac PR–RT are
under way and will help to elucidate the diﬀerences
between WT and mutant PR–RTs and also between
HIV-1 and SFVmac.
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